Triglyceride-Rich Lipoproteins (TRL)

Description

Triglyceride-rich Lipoproteins (TRL)
Catalog number: B2010392
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 mg
Molecular Weight or Concentration: 12,000-16,000 mg/dL
Supplied as: Solution
Appearance: Yellow/Orange
Applications: Triglyceride-rich lipoproteins (TRL) purified from human plasma. This highly concentrated triglyceride fraction can be used to test Triglycerides interference in immunoassays.
Storage: -20C
Keywords: Human triglycerides, TRL, HTF, TRIG, High Triglycerides, Concentrated Triglycerides, High Triglyceride Lipoproteins, human triacylglycerols, TAG.
Grade: Biotechnology grade. All solid components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL,
Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L,
Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A,
Watts GF; European Atherosclerosis Society Consensus Panel. Triglyceride-rich
lipoproteins and high-density lipoprotein cholesterol in patients at high risk
of cardiovascular disease: evidence and guidance for management. Eur Heart J.
2011 Jun;32(11):1345-61.

2: Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD. Triglyceride-
Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident
Cardiovascular Disease. J Am Coll Cardiol. 2020 May 5;75(17):2122-2135.

3: Botham KM, Wheeler-Jones CP. Postprandial lipoproteins and the molecular
regulation of vascular homeostasis. Prog Lipid Res. 2013 Oct;52(4):446-64.

4: Davidson MH. Triglyceride-rich lipoprotein cholesterol (TRL-C): the ugly
stepsister of LDL-C. Eur Heart J. 2018 Feb 14;39(7):620-622.

5: Sun CJ, McCudden C, Brisson D, Shaw J, Gaudet D, Ooi TC. Calculated Non-HDL
Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in
Hypertriglyceridemia. J Endocr Soc. 2019 Nov 3;4(1):bvz010.

6: Wolska A, Dunbar RL, Freeman LA, Ueda M, Amar MJ, Sviridov DO, Remaley AT.
Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in
triglyceride metabolism. Atherosclerosis. 2017 Dec;267:49-60.

7: Khetarpal SA, Zeng X, Millar JS, Vitali C, Somasundara AVH, Zanoni P, Landro
JA, Barucci N, Zavadoski WJ, Sun Z, de Haard H, Toth IV, Peloso GM, Natarajan P,
Cuchel M, Lund-Katz S, Phillips MC, Tall AR, Kathiresan S, DaSilva-Jardine P,
Yates NA, Rader DJ. A human APOC3 missense variant and monoclonal antibody
accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.
Nat Med. 2017 Sep;23(9):1086-1094.
8: Zhang Y, He W, He C, Wan J, Lin X, Zheng X, Li L, Li X, Yang X, Yu B, Xian X,
Zhu Y, Wang Y, Liu G, Lu N. Large triglyceride-rich lipoproteins in
hypertriglyceridemia are associated with the severity of acute pancreatitis in
experimental mice. Cell Death Dis. 2019 Sep 30;10(10):728.

Products Related to Triglyceride-rich Lipoproteins (TRL) : Interference